Publications by authors named "Anthony Dans"
Background: It is unclear whether modifying cholesterol, blood pressure, or both affect erectile dysfunction. Also, there are concerns that erectile dysfunction is worsened by common medications used to treat these risk factors. In this study, we evaluated the effect of: (1) cholesterol-lowering with a statin; (2) pharmacologic blood pressure reduction; and (3) their combination, on erectile function.
View Article and Find Full Text PDFArticle Synopsis
- Coronary artery disease (CAD) is a leading global health issue related to blood clots, and the study investigates whether factor Xa inhibitors (rivaroxaban) and aspirin can work together more effectively than separately in patients with stable CAD.
- Conducted across 33 countries with nearly 27,400 participants, the COMPASS trial randomly assigned patients to receive combinations of rivaroxaban and aspirin, rivaroxaban alone, or aspirin alone, while ensuring a double-blind method to maintain objectivity.
- Results indicated that the combination of rivaroxaban and aspirin significantly lowered the risk of major cardiovascular events compared to aspirin alone, with fewer instances of heart attacks and strokes among those taking the combined treatment.